Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Schizophrenia

  Free Subscription


13.04.2026

3 Acta Psychiatr Scand
1 Addict Behav
1 Can J Psychiatry
1 J Clin Psychiatry
1 Mol Psychiatry
4 Psychiatry Res
8 Psychol Med
3 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Psychiatr Scand

  1. MUSTONEN A, Niemela S, Denissoff A, Tanskanen A, et al
    Comparative Clinical Trajectories Across Cannabis-Related and Nonsubstance-Related Psychoses.
    Acta Psychiatr Scand. 2026 Apr 8. doi: 10.1111/acps.70097.
    PubMed         Abstract available

  2. KOUGIANOU I, Talukder A, Hare KO, Healy C, et al
    Selective Serotonin Reuptake Inhibitor Treatment in Adolescence and Subsequent Risk of Nonaffective Psychosis: A Quasi-Experimental Study.
    Acta Psychiatr Scand. 2026 Apr 7. doi: 10.1111/acps.70098.
    PubMed         Abstract available

  3. SERRA-NAVARRO M, Heilbronner M, Sole B, Borras R, et al
    Influence of Sex and Diagnosis on Clinical Variables and Neurocognitive Performance in Severe Mental Illness. Results From the PsyCourse Study.
    Acta Psychiatr Scand. 2026;153:449-467.
    PubMed         Abstract available


    Addict Behav

  4. RICCI V, Martinotti G, Maina G
    The role of hopelessness and depression in cannabis-induced first-episode psychosis: a 24-month prospective study.
    Addict Behav. 2026;179:108699.
    PubMed         Abstract available


    Can J Psychiatry

  5. LU Y, Todesco B, Hawke LD, Kozloff N, et al
    Optimizing Health for Canadian Youth at Clinical High Risk for Psychosis: A Feasibility Study: Optimiser la sante des jeunes Canadiens presentant un risque clinique eleve de psychose : Une etude de faisabilite.
    Can J Psychiatry. 2026 Apr 7:7067437261436536. doi: 10.1177/07067437261436536.
    PubMed         Abstract available


    J Clin Psychiatry

  6. MCINTYRE RS, Matthews DM, Arevalo C, McDonnell D, et al
    The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia.
    J Clin Psychiatry. 2026;87:25m16170.
    PubMed         Abstract available


    Mol Psychiatry

  7. YANG X, Agartz I, Andreassen O, Bachman P, et al
    Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis.
    Mol Psychiatry. 2026 Apr 4. doi: 10.1038/s41380-026-03586.
    PubMed         Abstract available


    Psychiatry Res

  8. TANG W, Guan C, Ling Z, Zhang X, et al
    Development of a risk prediction model for relapse in patients with schizophrenia based on a systematic review and meta-analysis.
    Psychiatry Res. 2026;361:117106.
    PubMed         Abstract available

  9. DANIEL DTG, Choi JJ, Aluri J, McCaulley C, et al
    Qualitative analysis of long-term clozapine adherence in schizophrenia: An exploratory study.
    Psychiatry Res. 2026;361:117136.
    PubMed         Abstract available

  10. OKA S, Yamazaki T, Takefuji Y
    Breaking the spline: Why distributed lag non-linear models miss thresholds in environmental psychiatry.
    Psychiatry Res. 2026;360:117104.
    PubMed         Abstract available

  11. XIAO D, Zhu C
    The role of serum BDNF levels in cognitive dysfunction among psychiatric disorders.
    Psychiatry Res. 2026;360:117069.
    PubMed         Abstract available


    Psychol Med

  12. MONISTROL-MULA A, Felez-Nobrega M, Byrne EM, Lind PA, et al
    The effect of polygenic liability to mental disorders on COVID-19 outcomes in people with depression: the mediating role of anxiety.
    Psychol Med. 2024;54:4140-4149.
    PubMed         Abstract available

  13. YILDIRIM B, Sahin SS, Gee A, Jauhar S, et al
    Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports.
    Psychol Med. 2024;54:4035-4047.
    PubMed         Abstract available

  14. KENDLER KS, Henrik O, Sundquist J, Sundquist K, et al
    Age at onset as an index of genetic heterogeneity in major psychiatric and substance use disorders.
    Psychol Med. 2024;54:4335-4347.
    PubMed         Abstract available

  15. AFTAB A
    Making sense of the literature on antipsychotics and long-term functioning: taking natural history and personalization seriously.
    Psychol Med. 2024;54:4485-4492.
    PubMed         Abstract available

  16. HUANG D, Liu Z, Tan W, Sopodenkiewicz M, et al
    Dynamic frontoparietal flexibility and cognitive dysfunction in schizophrenia: disentangling the roles of symptom burden and childhood trauma.
    Psychol Med. 2026;56:e93.
    PubMed         Abstract available

  17. LU ZA, Ploner A, Bergen SE
    Joint effects of childhood adversity and genetic risk for psychosis on psychopathology in the UK Biobank.
    Psychol Med. 2026;56:e92.
    PubMed         Abstract available

  18. HUANG H, Sun Y, Yin J, An S, et al
    Inflammatory cytokine alterations in genetic and clinical high risk groups of psychosis: a systematic review and network meta-analysis.
    Psychol Med. 2026;56:e99.
    PubMed         Abstract available

  19. O'MAHONY BW, Burke T, Hamill R, Gannon L, et al
    Interventions to prevent antipsychotic-induced weight gain and metabolic complications in individuals with a first-episode psychosis and minimal antipsychotic exposure: a systematic review and meta-analysis.
    Psychol Med. 2026;56:e101.
    PubMed         Abstract available


    Schizophr Res

  20. KU BS, Arrant EJ, Yuan QE, Aberizk KM, et al
    Social withdrawal and hippocampal volume among adolescents at clinical high risk for psychosis and healthy comparisons: The moderating role of neighborhood residential stability.
    Schizophr Res. 2026;293:81-90.
    PubMed         Abstract available

  21. GAO Y, Yan H, Hu R, Liu S, et al
    Effect of transcranial alternating current stimulation on auditory verbal hallucinations in patients with treatment-resistant schizophrenia.
    Schizophr Res. 2026;293:72-80.
    PubMed         Abstract available

  22. OH H, Goncalves CC, Arend JL, Blosnich JR, et al
    Sexual and gender minorities and psychosis research.
    Schizophr Res. 2026;293:67-68.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum